Nav: Home

John A. Kanis awarded ESCEO Medal of Excellence

April 14, 2016

Malaga, Spain - April 14, 2016 - Professor John A Kanis, Emeritus Professor in Human Metabolism, was announced the winner of the ESCEO Medal of Excellence. The prestigious award honours an academic who has contributed significantly to the field of osteoporosis and musculoskeletal science through original and outstanding scientific contributions.

ESCEO President Jean-Yves Reginster, Co-Chair of the World Congress, said, "I have had the privilege of collaborating with John Kanis for nearly two decades. Over this period, he contributed significantly to advances in the field including in the general management of osteoporosis and musculoskeletal disorders. As one of the bone field's most highly respected researchers and key opinion leaders, John Kanis continues a long career marked by outstanding and influential scientific scholarship."

Prof. John A. Kanis received his medical degree from the University of Edinburgh. After a MRC Clinical Research Fellow position at the Nuffield Orthopaedic Centre he became Wellcome Senior Research Fellow at the University of Oxford. He was then appointed Reader in Human Metabolism and Clinical Biochemistry at the University of Sheffield, where he is currently the Emeritus Professor in Human Metabolism. He is Editor of Osteoporosis International and serves on the editorial board of several journals. He is the author of more than 1200 papers, chapters and books on bone disease and metabolism. His current major interest is in the development of risk assessment algorithms and the formulation of practice guidelines in many regions of the world.

Professor Kanis stated: "It is an honour and privilege to receive this Award. It is also testimony to the hard work of so many excellent team members and collaborators who have contributed to our research programme, as well as the institutions that have provided such welcome support. We shall continue our efforts to understand the causes and develop preventive strategies against the consequences of osteoporosis and other disabling musculoskeletal conditions."
-end-
About the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO 2016) :

Held jointly by IOF and ESCEO, the Congress is taking place in Malaga, Spain from April 14-17,2016 is the world's largest annual forum for the presentation of clinical research and new advances in the prevention and management of bone, muscle and joint disorders, including sarcopenia and frailty. The next Congress will be held in Florence, Italy from March 23-26, 2017. For complete information visit http://www.wco-iof-esceo.org #OsteoCongress

About IOF :

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers, leading companies, as well as more than 234 patient, medical and research societies in 99 locations, work together to make bone, joint and muscle health a worldwide heath care priority. http://www.iofbonehealth.org / http://www.facebook.com/iofbonehealth / https://twitter.com/iofbonehealth

About ESCEO :

The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. http://www.esceo.org

International Osteoporosis Foundation

Related Osteoporosis Articles:

Mind the (osteoporosis treatment) gap!
A new review, referencing key clinical studies, guidelines and audits, outlines the main global challenges (and their solutions) facing healthcare professionals and policymakers responsible for providing care to populations in relation to bone health and fracture prevention.
Outwitting the 'silent thief' of osteoporosis
In a world first, new Australian research has revealed that genetic profiling can help predict whether an individual will break a bone through osteoporosis.
Osteoporosis: Antibody crystallized
Inhibiting a protein called Sclerostin could probably help treating the bone-loss disease osteoporosis.
JBMR perspective: A crisis in the treatment of osteoporosis
The remarkable progress made over the past 30 years to reduce fractures and dramatically improve the quality of life for millions of osteoporosis patients is rapidly being reversed, say two bone health experts in a Journal of Bone and Mineral Research article published online today.
The developmental origins of osteoporosis
Osteoporosis may have its origins in early life, but the consequences are not apparent until late adult life.
Task force provides guidance on use of osteoporosis drugs
A new report by a task force of the American Society for Bone and Mineral Research provides guidance on the use of bisphosphonates, which are the most commonly used medications for osteoporosis.
Whole genome-sequencing uncovers new genetic cause for osteoporosis
Using one of the world's most extensive genetics data sets, an international research team led by Dr.
Men far less likely to prevent, screen for osteoporosis
While the consequences of osteoporosis are worse in men than women -- including death -- older males are far less likely to take preventive measures against the potentially devastating bone-thinning disease or accept recommendations for screening, according to startling new research by North Shore-LIJ Health System geriatricians.
'Aquatic osteoporosis' jellifying lakes
North American lakes are suffering from declining calcium levels, says new research from Queen's University.
Osteoporosis, not just a woman's disease
While osteoporosis prevention and treatment efforts have historically been focused on post-menopausal women, a new study from Beth Israel Deaconess Medical Center suggests that critical opportunities are being lost by not focusing more attention on bone loss and fracture risk in older men.

Related Osteoporosis Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...